News and Announcements
Proteomics Technical Presentation
- Published October 27, 2015 4:12PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th October 2015, ASX Announcement
Life sciences company Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to provide its latest technical presentation on it lead diagnostic test, PromarkerD.
The presentation was given as part of the 11th Australian Peptide Conference 2015, which is being held in Kingscliff, New South Wales from 25th-30th October 2015. The Company’s Managing Director, Dr Richard Lipscombe, was invited to give the presentation at the conference’s opening satellite meeting, titled ‘The “Omics” Revolution: Uncovering Proteome Complexity’ on Sunday 25th October.
To read the full announcement and view the presentation, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
